CLNN.NASDAQClene INC
Form 4: Clene Inc. Director Jonathon Gay Acquires 3,716 Stock Options
Sentiment:
SEC Form 4
Director Jonathon Gay acquired 3,716 stock options in Clene Inc. on February 27, 2025, according to a Form 4 filing.
Summary
- On February 27, 2025, Jonathon Gay, a director of Clene Inc., acquired 3,716 stock options.
- The options were granted under the Clene Inc. Amended 2020 Stock Plan.
- The exercise price for the options is $4.42 per share.
- The options vest immediately upon grant and expire on February 26, 2035.
- The reporting person has direct ownership of the derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it reports a standard transaction of stock options grant to a director.
Positives
- The immediate vesting of the options could incentivize the director to work towards the company's success.
Industry Context
This is a standard practice for compensating and incentivizing company directors.
Comparison to Industry Standards
- Stock option grants to directors are a common practice in publicly traded companies to align their interests with those of shareholders.
- The vesting schedule and exercise price are typical components of such grants.
- Comparable companies in the biotechnology sector often use similar equity-based compensation plans.
Stakeholder Impact
- The stock option grant aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date of transaction: Grant of stock options. |
| 02/26/2035 | Expiration date of the stock options. |
| 02/28/2025 | Date of signature on the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.